16,302 Shares in Merck KGaA $MKGAF Purchased by Gables Capital Management Inc.

Gables Capital Management Inc. bought a new position in Merck KGaA (OTCMKTS:MKGAF) during the second quarter, Holdings Channel reports. The institutional investor bought 16,302 shares of the company’s stock, valued at approximately $2,095,000.

Merck KGaA Stock Up 1.2%

OTCMKTS:MKGAF opened at $160.21 on Wednesday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a 50 day moving average of $162.32 and a 200-day moving average of $148.21. The firm has a market capitalization of $20.71 billion, a PE ratio of 24.46 and a beta of 0.96. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56.

About Merck KGaA

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.